As of 3:21pm ET
| +0.06 / +2.21%|
The 5 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +188.81% increase from the last price of 2.77.
The current consensus among 5 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.